Found: 5
Select item for more details and to access through your institution.
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6760, doi. 10.3390/ijms25126760
- By:
- Publication type:
- Article
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1258108
- By:
- Publication type:
- Article
Dual Classification Approach for the Rapid Discrimination of Metabolic Syndrome by FTIR.
- Published in:
- Biosensors (2079-6374), 2023, v. 13, n. 1, p. 15, doi. 10.3390/bios13010015
- By:
- Publication type:
- Article
Extraction of Reduced Infrared Biomarker Signatures for the Stratification of Patients Affected by Parkinson's Disease: An Untargeted Metabolomic Approach.
- Published in:
- Chemosensors, 2022, v. 10, n. 6, p. 229, doi. 10.3390/chemosensors10060229
- By:
- Publication type:
- Article
SHAPING OF THE EVIDENCE-BASED SUBSTITUTION CONCEPTUAL FRAMEWORK OF THE ORIGINAL MEDICINES TO GENERIC COUNTERPARTS IN UKRAINE.
- Published in:
- ScienceRise: Pharmaceutical Science, 2021, v. 32, n. 4, p. 67, doi. 10.15587/2519-4852.2021.239431
- By:
- Publication type:
- Article